Show simple item record

dc.contributor.authorChow, Chi-Wing
dc.contributor.authorRincon, Mercedes
dc.contributor.authorDavis, Roger J.
dc.date2022-08-11T08:09:33.000
dc.date.accessioned2022-08-23T16:35:31Z
dc.date.available2022-08-23T16:35:31Z
dc.date.issued1999-02-18
dc.date.submitted2009-03-24
dc.identifier.citationMol Cell Biol. 1999 Mar;19(3):2300-7.
dc.identifier.issn0270-7306 (Print)
dc.identifier.pmid10022916
dc.identifier.urihttp://hdl.handle.net/20.500.14038/38578
dc.description.abstractThe nuclear factor of activated T cells (NFAT) transcription factor is implicated in expression of the cytokine interleukin-2 (IL-2). Binding sites for NFAT are located in the IL-2 promoter. Furthermore, pharmacological studies demonstrate that the drug cyclosporin A inhibits both NFAT activation and IL-2 expression. However, targeted disruption of the NFAT1 and NFAT2 genes in mice does not cause decreased IL-2 secretion. The role of NFAT in IL-2 gene expression is therefore unclear. Here we report the construction of a dominant-negative NFAT mutant (dnNFAT) that selectively inhibits NFAT-mediated gene expression. The inhibitory effect of dnNFAT is mediated by suppression of activation-induced nuclear translocation of NFAT. Expression of dnNFAT in cultured T cells caused inhibition of IL-2 promoter activity and decreased expression of IL-2 protein. Similarly, expression of dnNFAT in transgenic mice also caused decreased IL-2 gene expression. These data demonstrate that NFAT is a critical component of the signaling pathway that regulates IL-2 expression.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=10022916&dopt=Abstract">Link to Article in PubMed</a>
dc.subjectAnimals
dc.subjectCOS Cells
dc.subjectCell Line
dc.subjectCricetinae
dc.subjectDNA-Binding Proteins
dc.subject*Gene Expression Regulation
dc.subjectHumans
dc.subjectInterleukin-2
dc.subjectJurkat Cells
dc.subjectMice
dc.subjectMice, Transgenic
dc.subjectNFATC Transcription Factors
dc.subject*Nuclear Proteins
dc.subjectTranscription Factors
dc.subjectTranscription, Genetic
dc.subjectLife Sciences
dc.subjectMedicine and Health Sciences
dc.titleRequirement for transcription factor NFAT in interleukin-2 expression
dc.typeJournal Article
dc.source.journaltitleMolecular and cellular biology
dc.source.volume19
dc.source.issue3
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=2443&amp;context=oapubs&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/oapubs/1444
dc.identifier.contextkey794941
refterms.dateFOA2022-08-23T16:35:31Z
html.description.abstract<p>The nuclear factor of activated T cells (NFAT) transcription factor is implicated in expression of the cytokine interleukin-2 (IL-2). Binding sites for NFAT are located in the IL-2 promoter. Furthermore, pharmacological studies demonstrate that the drug cyclosporin A inhibits both NFAT activation and IL-2 expression. However, targeted disruption of the NFAT1 and NFAT2 genes in mice does not cause decreased IL-2 secretion. The role of NFAT in IL-2 gene expression is therefore unclear. Here we report the construction of a dominant-negative NFAT mutant (dnNFAT) that selectively inhibits NFAT-mediated gene expression. The inhibitory effect of dnNFAT is mediated by suppression of activation-induced nuclear translocation of NFAT. Expression of dnNFAT in cultured T cells caused inhibition of IL-2 promoter activity and decreased expression of IL-2 protein. Similarly, expression of dnNFAT in transgenic mice also caused decreased IL-2 gene expression. These data demonstrate that NFAT is a critical component of the signaling pathway that regulates IL-2 expression.</p>
dc.identifier.submissionpathoapubs/1444
dc.contributor.departmentHoward Hughes Medical Institute and Program in Molecular Medicine
dc.source.pages2300-7


Files in this item

Thumbnail
Name:
10022916.pdf
Size:
402.7Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record